Flutamide (Standard)

Flutamide (Standard) is the analytical standard of Flutamide. This product is intended for research and analytical applications. Flutamide is an Androgen Receptor antagonist with Ki=55 nM. Flutamide inhibits prostate cancer progression and has synergistic effects with Docetaxel (HY-B0011) . Flutamide also has the potential to protect against hyperthermia-induced multiple organ dysfunction syndrome[1][2][3][4][5][6][7].

Product Specifications

CAS Number

[13311-84-7]

Product Name Alternative

SCH 13521 (Standard)

UNSPSC

12352005

Hazard Statement

H302-H351-H361-H373-H411

Target

Androgen Receptor; Reference Standards

Type

Reference Standards

Related Pathways

Others; Vitamin D Related/Nuclear Receptor

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/flutamide-standard.html

Purity

99.80

Smiles

CC(C)C(NC1=CC=C([N+]([O-])=O)C(C(F)(F)F)=C1)=O

Molecular Formula

C11H11F3N2O3

Molecular Weight

276.21

Precautions

P260-P264-P270-P273-P280-P391-P405-P501

References & Citations

[1]Simard J, et al. Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues. Mol Cell Endocrinol. 1986 Mar;44 (3) :261-70.|[2]Luthy IA, et al. Androgenic activity of synthetic progestins and spironolactone in androgen-sensitive mouse mammary carcinoma (Shionogi) cells in culture. J Steroid Biochem. 1988 Nov;31 (5) :845-52.|[3]Crawford ED, et al. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. N Engl J Med. 1989 Aug 17;321 (7) :419-24.|[4]Rahimnia R, et al. The effect of Ganoderma lucidum polysaccharide extract on sensitizing prostate cancer cells to flutamide and docetaxel: an in vitro study. Sci Rep. 2023 Nov 2;13 (1) :18940.|[5]Lin CY, et al. Flutamide, an androgen receptor antagonist, improves heatstroke outcomes in mice. Eur J Pharmacol. 2012 Aug 5;688 (1-3) :62-7.|[6]Marchetti B, et al. Characteristics of flutamide action on prostatic and testicular functions in the rat. J Steroid Biochem. 1988 Jun;29 (6) :691-8.